Nicotine-antipsychotic drug interactions and attentional performance in female rats

European Journal of Pharmacology

Volumn 486, Issue 2, 2004, Pages 175-182

  Rezvani, Amir H ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attention; Clozapine; Cognition; Haloperidol; Risperidone; Signal detection task

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; NICOTINE; RISPERIDONE;

ACCURACY; ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG SCREENING; FEMALE; INJECTION; MEASUREMENT; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RELIABILITY; SIGNAL DETECTION; TASK PERFORMANCE; VISION;

EID: 1242351233     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.12.021     Document Type: Article

References (50)

1. Benedict R., Harris A., Markow T., McCormick J., Nuechterlein K., Asarmow R. Effects of attention training on information processing in schizophrenia. Schizophrenia Bulletin. 20:1994;537-546.
2. Benwell M.E.M., Balfour D.J.K. Regional variation in the effects of nicotine on catecholamine overflow in rat brain. European Journal of Pharmacology. 325:1997;13-20.
3. Brockel B.J., Fowler S.C. Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine. Journal of Pharmacology and Experimental Therapeutics. 275:1995;1090-1098.
4. Bushnell P. Behavioral approaches to the assessment of attention in animals. Psychopharmacology. 138:1998;231-259.
5. Bushnell P.J., Oshiro W.M., Padnos B.K. Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology. 134:1997;230-241.
6. Grenhoff J., Aston-Jones G., Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiologica Scandinavica. 128:1986;151-158.
7. Grilly D.M., Simon B.B., Levin E.D. Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal study. Pharmacology, Biochemistry and Behavior. 65:2000;665-670.
8. Hertel P., Nomikos G.G., Iurlo M., Svensson T.H. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology. 124:1996;74-86.
9. Lawrence A.D., Sahakian B.J. Alzheimer disease, attention, and the cholinergic system. Alzheimer Disease and Associated Disorders. 9:1995;43-49.
10. Levin E., Wilson W., Rose J., McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology. 15:1996;429-436.
11. Levin E.D., Conners C.K., Sparrow E., Hinton S., Meck W., Rose J.E., Ernhardt D., March J. Nicotine effects on adults with attention-deficit/ hyperactivity disorder. Psychopharmacology. 123:1996;55-63.
12. Levin E.D., Conners C.K., Silva D., Hinton S.C., Meck W., March J., Rose J.E. Transdermal nicotine effects on attention. Psychopharmacology. 140:1998;135-141.
13. Levin E.D., Conners C.K., Silva D., Canu W., March J. Effects of chronic nicotine and methylphenidate in adults with ADHD. Experimental and Clinical Psychopharmacology. 9:2001;83-90.
14. Leysen J.E., Gommeren W., Eens A., de Chaffoy de Courcelles D., Stoof J.C., Janssen P.A. Biochemical profile of risperidone, a new antipsychotic. Journal of Pharmacology and Experimental Therapeutics. 247:1988;661-670.
15. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer R. Prenatal adverse effects of nicotine on the developing brain. Progress in Brain Research. 73:1988;137-157.
16. Lieberman J., Mailman R., Duncan G., Sikich L., Chakos M., Nichols D., Kraus J. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry. 44:1998;1099-1117.
17. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophrenia Research. 8:1992;93-102.
18. Matsubara S., Matsubara R., Kusumi I., Koyama T., Yamashita I. Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. Journal of Pharmacology and Experimental Therapeutics. 265:1993;498-508.
19. McGaughy J., Kaiser T., Sarter M. Behavioral vigilance following infusions of 192 IgG-Sapoin into the basal forbrain: selectivity of the behavioral impairment and relation to cortical ACh-positive fiber density. Behavioral Neuroscience. 110:1996;247-265.
20. McGaughy J., Decker M.W., Sarter M. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology. 144:1999;175-182.
21. Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin. 25:1999;233-255.
22. Mirza N.R., Bright J.L. Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharmacology. 154:2001;8-12.
23. Mirza N.R., Stolerman I.P. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology. 138:1998;266-274.
24. Muir J.L., Everitt B.J., Robbins T.W. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology. 118:1995;82-92.
25. Murrin L.C., Ferrer J.R., Wanyun Z., Haley N.J. Nicotine administration to rats: methodological considerations. Life Sciences. 40:1987;1699-1708.
26. Nieoullon A. Dopamine and the regulation of cognition and attention. Progress in Neurobiology. 67:2002;53-83.
27. Nuechterlein K. Vigilance in schizophrenia and related disorders. Steinhauer S., Gruzelier J., Zubin J. Handbook of Schizophrenia. Neuropsychology, Psychophysiology and Information Processing. vol. 5:1991;397-433 Elsevier, Amsterdam.
28. Oades R., Rao M., Bender S., Sartory G., Muller B. Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor. Behavioural Pharmacology. 11:2000;7-23.
29. Peeke S.C., Peeke H.V.S. Attention, memory, and cigarette smoking. Psychopharmacology. 84:1984;205-216.
30. Rezvani A.H., Levin E. Nicotine interactions with the NMDA glutaminergic antagonist dizocilpine and attentional function. European Journal of Pharmacology. 465:2003;83-90.
31. Rezvani A.H., Levin E. Nicotine-alcohol interactions and attentional performance on an operant visual signal detection task in female rats. Pharmacology, Biochemistry and Behavior. 76:2003;75-83.
32. Rezvani A.H., Bushnell P.J., Burkholder J.M., Glasgow H.B., Levin E.D. Specificity of cognitive impairment from Pfiesteria piscicida exposure in rats: attention and visual function vs. behavioral plasticity. Neurotoxicology and Teratology. 23:2001;609-616.
33. Rezvani A.H., Bushnell P., Levin E. Nicotine and mecamylamine effects on choice accuracy in an operant signal detection task. Psychopharmacology. 164:2002;369-375.
34. Rezvani A.H., Caldwaell D.P., Levin E. Nicotinic-serotonergic drug interactions and attentional performance in rats. Psychopharmacology. 2004;. (Under review).
35. Richelson E., Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sciences. 68:2000;29-39.
36. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. British Journal of Psychiatry. 154:1989;797-800.
37. Sarter M., Givens B., Bruno J. The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Research Reviews. 35:2001;146-160.
38. Schotte A., Janssen P., Megens A., Leysen J. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research. 631:1993;191-202.
39. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., De Loore K., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124:1996;57-73.
40. Slotkin T.A. Prenatal exposure to nicotine: what can we learn from animal models? Zagon I.S., Slotkin T.A. Maternal Substance Abuse and the Developing Nervous System. 1992;97-124 Academic Press, New York.
41. Stolerman I.P., Mirza N.R., Hahn B., Shoaib M. Nicotine in an animal model of attention. European Journal of Pharmacology. 393:2000;147-154.
42. Sumiyoshi T., Kido H., Sakamoto H., Urasaki K., Suzuki K., Yamaguchi N., Mori H., Shiba K., Yokogawa K. In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol. Pharmacology, Biochemistry and Behavior. 47:1994;553-557.
43. Trauth J.A., Seidler F.J., McCook E.C., Slotkin T.A. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Research. 851:1999;9-19.
44. Turchi J., Holley L.A., Sarter M. Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Psychopharmacology. 118:1995;195-205.
45. Warburton D.M., Rusted J.M., Fowler J. A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology. 108:1992;443-447.
46. Westerink B. Can antipsychotic drugs be classified by their effects on a paricular group of dopamine neurons in the brain? European Journal of Pharmacology. 455:2002;1-18.
47. White H.K., Levin E.D. Chronic four week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology. 143:1999;158-165.
48. White H., Levin E. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology. 2004;. (in press).
49. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends in Neurosciences. 20:1997;92-98 Elsevier, Amsterdam.
50. Wonnacott S., Irons J., Rapier C., Thorne B., Lunt G.G. Presynaptic modulation of transmitter release by nicotinic receptors. Nordberg A., Fuxe K., Holmstedt B., Sundwall A. Progress in Brain Research. vol. 79:1989;157-163 Elsevier, Amsterdam.